Vincerx Pharma, Inc. VINC
Set alert
0.01 USD 0.00 0.00%
At close · Feb 5
0.06 +0.05 +391.54%
After hours · Feb 5, 4:00 PM ET
0.0053 Day range 0.0053
0.001 52-week range 0.026
- YTD
- 0.00%
- 1 year
- -75.00%
- Open
- 0.0053
- Prev close
- 0.013
- Mkt cap
- 68.05K
- Vol
- 22
- Avg vol
- 1.69K
- EPS
- -9.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0053
- High
- 0.0053
- Forward P/E
- -0.30
- Beta
- 0.00
- Short ratio
- 2.22
- Inst. own
- 24.80%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 0.29914
- 200-d avg
- 1.16
- 1y target
- 6.00
Analyst view
Consensus: none
Price target (mean) 6.00 +46053.8% upside
Now 0.013
- Target (low)
- 2.00
- Target (mean)
- 6.00
- Target (high)
- 10.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.3376 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 8, 2024 | Leerink Partners | Maintained | Outperform | Outperform |
| Apr 9, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Apr 1, 2024 | Cantor Fitzgerald | Reiterated | — | Overweight |
| Sep 7, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Nov 17, 2022 | Chardan Capital | Maintained | — | Buy |
| Aug 12, 2022 | SVB Leerink | Maintained | — | Outperform |
| Jun 8, 2022 | Cantor Fitzgerald | Maintained | — | Overweight |
| Jun 7, 2022 | B. Riley Securities | Maintained | — | Buy |
| Jun 7, 2022 | Chardan Capital | Maintained | — | Buy |
| Jun 7, 2022 | SVB Leerink | Maintained | — | Outperform |
| May 13, 2022 | Chardan Capital | Maintained | — | Buy |
| May 13, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 30, 2022 | SVB Leerink | Maintained | — | Outperform |
| Mar 30, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 14, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Dec 23, 2021 | Cantor Fitzgerald | Initiated | — | Overweight |
| Nov 1, 2021 | SVB Leerink | Initiated | — | Outperform |
| Sep 13, 2021 | Laidlaw & Co. | Initiated | — | Buy |
| Aug 25, 2021 | B. Riley Securities | Initiated | — | Buy |
| Aug 13, 2021 | Chardan Capital | Maintained | — | Buy |
| Jan 6, 2021 | Chardan Capital | Initiated | — | Buy |